348 related articles for article (PubMed ID: 19496740)
21. Medication adherence and persistence as the cornerstone of effective antihypertensive therapy.
Burnier M
Am J Hypertens; 2006 Nov; 19(11):1190-6. PubMed ID: 17070434
[TBL] [Abstract][Full Text] [Related]
22. Public health value of fixed-dose combinations in hypertension.
Ruilope LM; Burnier M; Muszbek N; Brown RE; Keskinaslan A; Ferber P; Harms G
Blood Press Suppl; 2008 Jun; 1():5-14. PubMed ID: 18705530
[TBL] [Abstract][Full Text] [Related]
23. [Fixed-dose combinations in antihypertensive treatment: is it necessary to examine the effectiveness of each component?].
Dechend R; Derer W; Müller DN
MMW Fortschr Med; 2009 Nov; 151(45):46-7. PubMed ID: 19960726
[No Abstract] [Full Text] [Related]
24. Achieving Goal Blood Pressure.
Laurent S
High Blood Press Cardiovasc Prev; 2015 Jul; 22 Suppl 1():S5-9. PubMed ID: 26002423
[TBL] [Abstract][Full Text] [Related]
25. Low-dose fixed combination of bisoprolol/hydrochlorothiazide as first line for hypertension: a review of the rationale and clinical evidence.
Papadopoulos DP; Papademetriou V
Angiology; 2009; 60(5):601-7. PubMed ID: 19028769
[TBL] [Abstract][Full Text] [Related]
26. [Advantage and disadvantages of single-pill (fixed) antihypertensive drug combinations].
Umemura S
Nihon Rinsho; 2011 Nov; 69(11):2042-8. PubMed ID: 22111328
[TBL] [Abstract][Full Text] [Related]
27. [No response to antihypertensive therapy: consider non-adherence].
Braam RL; Van Uum SH; Lenders JW; Thien T
Ned Tijdschr Geneeskd; 2007 Mar; 151(10):569-73. PubMed ID: 17402645
[TBL] [Abstract][Full Text] [Related]
28. Adherence to antihypertensive medications and cardiovascular morbidity among newly diagnosed hypertensive patients.
Mazzaglia G; Ambrosioni E; Alacqua M; Filippi A; Sessa E; Immordino V; Borghi C; Brignoli O; Caputi AP; Cricelli C; Mantovani LG
Circulation; 2009 Oct; 120(16):1598-605. PubMed ID: 19805653
[TBL] [Abstract][Full Text] [Related]
29. Improving compliance with antihypertensive therapy.
Moore MA
Am Fam Physician; 1988 Jan; 37(1):142-8. PubMed ID: 3276096
[TBL] [Abstract][Full Text] [Related]
30. Rationale for combination therapy in the treatment of hypertension.
Sica DA
J Renin Angiotensin Aldosterone Syst; 2002 Jun; 3(2):63-5. PubMed ID: 12228844
[TBL] [Abstract][Full Text] [Related]
31. [Refractory hypertension].
Os I; Eide IK; Westheim AS; Kjeldsen SE
Tidsskr Nor Laegeforen; 1995 Feb; 115(6):723-4. PubMed ID: 7900136
[TBL] [Abstract][Full Text] [Related]
32. Single-pill combination therapy in hypertension: a rational or emotional construct?
McIntyre HF; Haydock PM
Int J Clin Pract; 2009 May; 63(5):682-4. PubMed ID: 19392916
[No Abstract] [Full Text] [Related]
33. Combination therapy in hypertension: an Asia-Pacific consensus viewpoint.
Abdul Rahman AR; Reyes EB; Sritara P; Pancholia A; Van Phuoc D; Tomlinson B
Curr Med Res Opin; 2015 May; 31(5):865-74. PubMed ID: 25707364
[TBL] [Abstract][Full Text] [Related]
34. Benefits and risks of combination therapy in hypertension.
Node K
Hypertens Res; 2009 Sep; 32(9):727-8. PubMed ID: 19609269
[No Abstract] [Full Text] [Related]
35. Clinical practice. Resistant or difficult-to-control hypertension.
Moser M; Setaro JF
N Engl J Med; 2006 Jul; 355(4):385-92. PubMed ID: 16870917
[No Abstract] [Full Text] [Related]
36. Facts and fallacies of blood pressure control in recent trials: implications in the management of patients with hypertension.
Zanchetti A; Mancia G; Black HR; Oparil S; Waeber B; Schmieder RE; Bakris GL; Messerli FH; Kjeldsen SE; Ruilope LM
J Hypertens; 2009 Apr; 27(4):673-9. PubMed ID: 19516168
[TBL] [Abstract][Full Text] [Related]
37. Fixed-dose combinations of renin-angiotensin blocking agents with calcium channel blockers or hydrochlorothiazide in the treatment of hypertension.
Bramlage P
Expert Opin Pharmacother; 2009 Aug; 10(11):1755-67. PubMed ID: 19538001
[TBL] [Abstract][Full Text] [Related]
38. Management of hypertension in the outpatient setting.
Sica DA
Prim Care; 2008 Sep; 35(3):451-73, vi. PubMed ID: 18710664
[TBL] [Abstract][Full Text] [Related]
39. Combination agents as a means of improving adherence and other aspects of the sixth Joint National Committee Report.
Basile JN
South Med J; 2000 May; 93(5):534-6. PubMed ID: 10832960
[No Abstract] [Full Text] [Related]
40. Resistant hypertension.
Silverstein RL; Ram CV
Prim Care; 2008 Sep; 35(3):501-13, vii. PubMed ID: 18710667
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
